Alnylam Pharmaceuticals
ALNY
#582
Rank
C$49.28 B
Marketcap
$380.78
Share price
-1.34%
Change (1 day)
83.39%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no stock splits for this company